{"id":6519,"date":"2012-12-24T01:56:03","date_gmt":"2012-12-24T06:56:03","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=6519"},"modified":"2012-12-24T01:56:03","modified_gmt":"2012-12-24T06:56:03","slug":"stocks-outlook-for-2013","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/","title":{"rendered":"Stocks: Outlook for 2013"},"content":{"rendered":"

Quarterly charts for the last two decades give a good idea of where stocks will be headed in 2013.<\/p>\n

The S&P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum indicates that resistance is unlikely to be broken. While this does not mean another fall to 750, it does suggest a strong correction.<\/p>\n

\"S&P<\/p>\n

Apple Inc. [AAPL] is no longer leading the advance but testing primary support at 500. Failure of support would confirm the primary down-trend indicated by a 63-day Twiggs Momentum peak below zero.<\/p>\n

\"Apple\"<\/p>\n

Germany’s DAX is also headed for a test of its 2000\/2007 high, at 8200, but rising momentum indicates that breakout above resistance is likely.<\/p>\n

\"DAX<\/p>\n

The FTSE 100 is also advancing but is some way off its earlier high of 7000 and breakout appears unlikely.<\/p>\n

\"FTSE<\/p>\n

India’s Sensex is more bullish and likely to break resistance at 21000.<\/p>\n

\"BSE<\/p>\n

The Shanghai Composite is headed in the opposite direction and likely to re-test long-term support at 1800\/1750. Rising 63-day Twiggs Momentum (below zero) suggests that a bottom will form at this level.<\/p>\n

\"Shanghai<\/p>\n

The ASX 200 is headed for a test of resistance at 5000, supported by rising 63-day Twiggs Momentum. Breakout would signal an advance to 6000, but weakness in China and the US may delay this for some time.<\/p>\n

\"ASX<\/p>\n","protected":false},"excerpt":{"rendered":"

Quarterly charts for the last two decades give a good idea of where stocks will be headed in 2013. The S&P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum indicates that resistance is unlikely to be broken. While this does not mean another fall to 750, it … <\/p>\n

Continue reading “Stocks: Outlook for 2013”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[40,41,12,57,33,34],"tags":[107,251,507,947,1481,3014,3100],"class_list":["post-6519","post","type-post","status-publish","format-standard","hentry","category-australia-nz-countries-regions","category-china-hk","category-india-singapore-countries-regions","category-stock-markets","category-uk-europe-countries-regions","category-us-canada-countries-regions","tag-aapl","tag-asx-200","tag-bse-sensex","tag-dax","tag-ftse-100","tag-sp-500-index","tag-shanghai-composite-index"],"yoast_head":"\nStocks: Outlook for 2013 - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stocks: Outlook for 2013 - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Quarterly charts for the last two decades give a good idea of where stocks will be headed in 2013. The S&P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum indicates that resistance is unlikely to be broken. While this does not mean another fall to 750, it … Continue reading "Stocks: Outlook for 2013"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2012-12-24T06:56:03+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Stocks: Outlook for 2013\",\"datePublished\":\"2012-12-24T06:56:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/\"},\"wordCount\":208,\"commentCount\":6,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png\",\"keywords\":[\"AAPL\",\"ASX 200\",\"BSE Sensex\",\"DAX\",\"FTSE 100\",\"S&P 500 Index\",\"Shanghai Composite Index\"],\"articleSection\":[\"Australia & NZ\",\"China & HK\",\"India & Singapore\",\"Stock Markets\",\"UK & Europe\",\"US & Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/\",\"name\":\"Stocks: Outlook for 2013 - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png\",\"datePublished\":\"2012-12-24T06:56:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stocks: Outlook for 2013\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\",\"https:\/\/au.linkedin.com\/in\/colintwiggs\"],\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stocks: Outlook for 2013 - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Stocks: Outlook for 2013 - the patient investor","og_description":"Quarterly charts for the last two decades give a good idea of where stocks will be headed in 2013. The S&P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum indicates that resistance is unlikely to be broken. While this does not mean another fall to 750, it … Continue reading \"Stocks: Outlook for 2013\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2012-12-24T06:56:03+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Stocks: Outlook for 2013","datePublished":"2012-12-24T06:56:03+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/"},"wordCount":208,"commentCount":6,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png","keywords":["AAPL","ASX 200","BSE Sensex","DAX","FTSE 100","S&P 500 Index","Shanghai Composite Index"],"articleSection":["Australia & NZ","China & HK","India & Singapore","Stock Markets","UK & Europe","US & Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/","name":"Stocks: Outlook for 2013 - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png","datePublished":"2012-12-24T06:56:03+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2012\/2012-12-24-spx.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Stocks: Outlook for 2013"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-1H9","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":6546,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/","url_meta":{"origin":6519,"position":0},"title":"Stocks: The year ahead","author":"Colin Twiggs","date":"January 17, 2013","format":false,"excerpt":"A quick recap of the quarterly chart overview from December 2012: The S&P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum and a lackluster economy suggest that resistance is unlikely to be broken. Breach of the rising trendline would indicate a test\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":13766,"url":"https:\/\/thepatientinvestor.com\/index.php\/2015\/03\/12\/dax-surges-ahead-while-others-retreat\/","url_meta":{"origin":6519,"position":1},"title":"DAX surges ahead while others retreat","author":"ColinTwiggs","date":"March 12, 2015","format":false,"excerpt":"The DAX is headed for its long-term target of 12000 while most markets (other than Japan) undergo a correction. The S&P 500 broke support at 2080, indicating a correction to test 2000. Breach of primary support is unlikely and another 13-week Twiggs Money Flow trough above zero would signal another\u2026","rel":"","context":"In "Market Insights"","block_context":{"text":"Market Insights","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/market-insights\/"},"img":{"alt_text":"S&P 500 Index","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-03-12-spx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-03-12-spx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-03-12-spx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":6937,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/03\/12\/europe-ftse-and-european-markets-rising\/","url_meta":{"origin":6519,"position":2},"title":"Europe: FTSE and European markets rising","author":"Colin Twiggs","date":"March 12, 2013","format":false,"excerpt":"The FTSE 100 broke out from its rising flag on the weekly chart and is headed for a test of resistance between 6800* (the high from 2007) and 7000 (from 1999). Rising 13-week Twiggs Momentum indicates strong buying pressure. * Target calculation: 6400 + ( 6400 - 6000 ) =\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":13763,"url":"https:\/\/thepatientinvestor.com\/index.php\/2015\/02\/19\/broad-market-rally\/","url_meta":{"origin":6519,"position":3},"title":"Broad market rally","author":"ColinTwiggs","date":"February 19, 2015","format":false,"excerpt":"Major indices across the US, Europe and Japan are displaying strong performance. China and India appear to be encountering stronger resistance, but should also be buoyed by the broad recovery. Bellwether transport stock Fedex (FDX) is headed for another test of resistance at $182\/$184. Breakout would signal a primary advance,\u2026","rel":"","context":"In "Market Insights"","block_context":{"text":"Market Insights","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/market-insights\/"},"img":{"alt_text":"Fedex","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-02-18-fdx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-02-18-fdx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-02-18-fdx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":6275,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/11\/26\/europe-dax-heads-for-7500\/","url_meta":{"origin":6519,"position":4},"title":"Europe: DAX heads for 7500","author":"Colin Twiggs","date":"November 26, 2012","format":false,"excerpt":"Germany's Dax rallied off support at 7000 and is headed for a test of resistance at 7500. Breakout would signal an advance to 8000*. Oscillation of 13-week Twiggs Money Flow above zero indicates buying pressure. Reversal below 7000 is unlikely but would warn that a top is forming. * Target\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":4748,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/07\/03\/uk-and-europe-tentative-recovery\/","url_meta":{"origin":6519,"position":5},"title":"UK and Europe: Tentative recovery","author":"Colin Twiggs","date":"July 3, 2012","format":false,"excerpt":"The FTSE 100 index broke resistance (and the descending trendline) at 5600\/5620, suggesting the correction has ended. Oscillation of 63-day Twiggs Momentum around zero is narrowing, indicating hesitancy. Follow-through above 5650 would strengthen the breakout signal -- as would recovery of 63-day Twiggs Momentum above zero -- targeting 6000*. Reversal\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/6519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=6519"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/6519\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=6519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=6519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=6519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}